Case number 2024-1567
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 20, 2024 | 6 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [1022706-2] filed by Appellant Regeneron Pharmaceuticals, Inc. in 24-1564. The appeals are dismissed. Each party shall bear its own costs for each appeal.; issuing mandate. Service as of this date by the Clerk of Court. [1026272] [24-1564, 24-1567] [NL] [Entered: 08/20/2024 11:37 AM] (2) |
| Apr 23, 2024 | 5 | Certified list received. Service: 04/22/2024 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [999437] [24-1564, 24-1567] [JSP] [Entered: 04/23/2024 12:50 PM] (185) |
| Mar 25, 2024 | 3 | ORDER consolidating appeals (24-1564, 24-1567). The Certified Lists are due no later than April 22, 2024.. Service as of this date by the Clerk of Court. [992679] [24-1564, 24-1567] [JSP] [Entered: 03/25/2024 12:35 PM] (2) |
| Mar 25, 2024 | 4 | Note to File: The following cases are consolidated: 24-1564 Lead with 24-1567 Member appeal. The parties must file all documents in the lead appeal only. [992680] [24-1564, 24-1567] [JSP] [Entered: 03/25/2024 12:36 PM] (0) |
| Mar 13, 2024 | 1 | Appeal docketed. Received: 03/12/2024. [990408] Entry of Appearance is due on 03/27/2024. Certificate of Interest is due on 03/27/2024. Docketing Statement is due on 03/27/2024. Certified List is due on 04/22/2024. [JSP] [Entered: 03/13/2024 12:14 PM] (0) |
